share_log

Marpai | 8-K: MARPAI reports FOURTH QUARTER AND FULL YEAR 2023 financial results

Marpai | 8-K: Current report

Marpai | 8-K：重大事件
SEC announcement ·  03/26 17:21
Moomoo AI 已提取核心信息
On March 26, 2024, Marpai, Inc., a Third-Party Administration company operating in the healthcare sector, released its financial results for the fourth quarter and the full year of 2023. The report highlighted a year-over-year improvement in net revenues, gross profit, and a reduction in operating loss and net loss for the quarter. Specifically, Q4 net revenues increased by 14% to $8.7 million, gross profit rose by 6.5% to $3.0 million, and operating loss and net loss improved by 42.3% and 41.1%, respectively. For the full year, net revenues saw a significant increase of 52.6% to $37.2 million, and gross profit surged by 79.2% to $12.9 million. However, operating expenses and net loss also increased compared to the previous year. The company attributes part of its financial improvement to the acquisition of Maestro Health and corrective actions taken in Q4. Marpai's CEO, Damien Lamendola, emphasized the company's commitment to reducing costs for clients and improving care quality. A webcast to discuss these results is scheduled for March 27, 2024.
On March 26, 2024, Marpai, Inc., a Third-Party Administration company operating in the healthcare sector, released its financial results for the fourth quarter and the full year of 2023. The report highlighted a year-over-year improvement in net revenues, gross profit, and a reduction in operating loss and net loss for the quarter. Specifically, Q4 net revenues increased by 14% to $8.7 million, gross profit rose by 6.5% to $3.0 million, and operating loss and net loss improved by 42.3% and 41.1%, respectively. For the full year, net revenues saw a significant increase of 52.6% to $37.2 million, and gross profit surged by 79.2% to $12.9 million. However, operating expenses and net loss also increased compared to the previous year. The company attributes part of its financial improvement to the acquisition of Maestro Health and corrective actions taken in Q4. Marpai's CEO, Damien Lamendola, emphasized the company's commitment to reducing costs for clients and improving care quality. A webcast to discuss these results is scheduled for March 27, 2024.
2024年3月26日，在医疗保健领域运营的第三方管理公司Marpai, Inc. 发布了第四季度和2023年全年的财务业绩。该报告强调了本季度净收入、毛利同比增长以及营业亏损和净亏损的减少。具体而言，第四季度净收入增长了14％，达到870万美元，毛利增长了6.5％，达到300万美元，营业亏损和净亏损分别增长了42.3％和41.1％。全年净收入大幅增长52.6％，达到3,720万美元，毛利增长79.2％，至1,290万美元。但是，与去年相比，运营费用和净亏损也有所增加。该公司将其财务改善的一部分归因于对Maestro Health的收购以及第四季度采取的纠正措施。Marpai首席执行官达米安·拉门多拉强调了该公司对降低客户成本和提高护理质量的承诺。讨论这些结果的网络直播定于2024年3月27日举行。
2024年3月26日，在医疗保健领域运营的第三方管理公司Marpai, Inc. 发布了第四季度和2023年全年的财务业绩。该报告强调了本季度净收入、毛利同比增长以及营业亏损和净亏损的减少。具体而言，第四季度净收入增长了14％，达到870万美元，毛利增长了6.5％，达到300万美元，营业亏损和净亏损分别增长了42.3％和41.1％。全年净收入大幅增长52.6％，达到3,720万美元，毛利增长79.2％，至1,290万美元。但是，与去年相比，运营费用和净亏损也有所增加。该公司将其财务改善的一部分归因于对Maestro Health的收购以及第四季度采取的纠正措施。Marpai首席执行官达米安·拉门多拉强调了该公司对降低客户成本和提高护理质量的承诺。讨论这些结果的网络直播定于2024年3月27日举行。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息